Patients should be aware that some falsified medicines have been found to contain insulin, which if used, could cause severe hypoglycaemia, requiring urgent medical attention
The first component, tirzepatide, is a dual GIP and GLP-1 receptor agonist that reduces appetite, slows gastric emptying, and improves insulin sensitivity
Therefore, it is advisable for people to discuss the potential risk and benefits of GLP-1 medications with their healthcare providers
[1] One study found that vegans showed no signs of carnitine deficiency
Yes, but adjust based on metabolic response, not scale movement alone
Emerging data supports GLP-1s cardiovascular benefits, outweighing risks for most, but shared decision-making is key